[Treatment of juvenile idiopathic arthritis].
Yokota
Shunpei
S
Department of Pediatrics, Yokohama City University School of Medicine.
Umebayashi
Hiroaki
H
Katakura
Shigeki
S
Imagawa
Tomoyuki
T
Mori
Masaaki
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D015850:Interleukin-6 / Q000276:immunology; D008727:Methotrexate / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015850:Interleukin-6; D011239:Prednisolone; D000069285:Infliximab; D008727:Methotrexate